Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that positive results from the ongoing TransCarotid Artery Revascularization (TCAR) Surveillance Project comparing TCAR and transfemoral carotid artery stenting (TF-CAS) have been published in The Journal of the American Medical Association (JAMA).
Read More: www.streetinsider.com/Corporate+News/Silk+Road+Medical+%28SILK%29+Announces+Results+Demonstrating+Favorable+Outcomes+with+TCAR+vs.+TF-CAS+in+Patients+with+Carotid+Artery+Stenosis+Published+in+JAMA/16253818.html